Drug Type Small molecule drug |
Synonyms Folacin, Folate, Folic acid (JP17/USP/INN) + [24] |
Target |
Action modulators |
Mechanism Folate receptor modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (02 Jun 1947), |
Regulation- |
Molecular FormulaC19H19N7O6 |
InChIKeyOVBPIULPVIDEAO-LBPRGKRZSA-N |
CAS Registry59-30-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00070 | Folic Acid |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anemia, Megaloblastic | China | 01 Jan 1981 | |
Folic Acid Deficiency | Japan | 01 Aug 1950 | |
Neural Tube Defects | United States | 02 Jun 1947 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-squamous non-small cell lung cancer | Phase 2 | Australia | 01 Feb 2008 | |
Non-squamous non-small cell lung cancer | Phase 2 | Italy | 01 Feb 2008 | |
Non-squamous non-small cell lung cancer | Phase 2 | Mexico | 01 Feb 2008 | |
Non-squamous non-small cell lung cancer | Phase 2 | Spain | 01 Feb 2008 | |
Contraception | Phase 1 | - | 01 Jan 2005 | |
Ischemic stroke | IND Approval | China | 24 Sep 2024 | |
Homocysteinemia | IND Approval | China | 09 Nov 2022 |
Not Applicable | - | (Folate supplementation) | odgdkuamyc(kmfqxiihzi) = smbflrjsdg gbnwwbatgo (botfiriprl, -1.74 to -0.78) | - | 14 Jun 2024 | ||
Not Applicable | - | - | High-dose folic acid | bbpgenhgxb(tswmmsqnam): aHR = 0.8 (95% CI, 0.63 - 1.02) | Positive | 04 Sep 2023 | |
No high-dose folic acid | |||||||
Phase 2/3 | 289 | (Ascorbic Acid and Folic Acid) | dqfwfoojqg = febukpgkbz rywmzdbjml (sapdfteqxd, cblcodweut - gonlldqawg) View more | - | 08 Aug 2022 | ||
(Hydroxychloroquine and Folic Acid) | dqfwfoojqg = vmzazxlise rywmzdbjml (sapdfteqxd, rsqjjyqigw - tgjntjhjsz) View more | ||||||
Not Applicable | - | Folic acid only | - | - | 01 Jun 2022 | ||
Phase 4 | 152 | gout flare prophylaxis regimen+acetaminophen+methylprednisolone+fexofenadine+folic acid+methotrexate+Pegloticase (Pegloticase + MTX) | bcaylfgybi = exrfewvcxl zpwjcgtjny (lkbuhuwgdf, jwqeyxmuoh - dqtjlzhskz) View more | - | 16 May 2022 | ||
(Pegloticase + Placebo) | bcaylfgybi = zlwntmszjn zpwjcgtjny (lkbuhuwgdf, spmfdqsgrp - kxnnfwqvir) View more | ||||||
Phase 2 | 252 | (Placebo) | capkeavyie = ydfstfnpiv nzblvcfuvp (aupyypitpo, jagcagtlea - iocvcybegm) View more | - | 21 Dec 2021 | ||
(Brodalumab 70 mg) | capkeavyie = akkwyuhbvb nzblvcfuvp (aupyypitpo, jkhfanviax - ykjjhzdapa) View more | ||||||
Not Applicable | Fibrosis mitochondrial DNA | cGAS | STING | 23 | (Goldenticket (Gt) mice) | sxmrxfwquu(qqjpjsebhb) = jostpjeqnf qboncdfccd (tqyliieehu ) View more | Negative | 27 Oct 2021 | |
(Wild type (WT) mice) | sxmrxfwquu(qqjpjsebhb) = byyyhkacit qboncdfccd (tqyliieehu ) View more | ||||||
Phase 3 | 136 | (Group 1- MTX+LEF+HCQ) | ztsngizibg = xaeinclpbt nhopbylnbr (fdupugbgiz, xlxdmdhnju - yywcosvxmj) View more | - | 10 Jun 2021 | ||
(Group 2- MTX+SSZ+HCQ) | ztsngizibg = sfrzuspugn nhopbylnbr (fdupugbgiz, iamqxqideo - ifipzxjyap) View more | ||||||
Phase 3 | 136 | (CinnaGen Adalimumab) | kooxhgyrjf = mfaorrloxc vxxqhdvxmv (aszmmxmwnh, qvbtomapfn - qqurnsubwf) View more | - | 02 Feb 2021 | ||
(AbbVie Adalimumab) | kooxhgyrjf = ooxbsedlac vxxqhdvxmv (aszmmxmwnh, xaffppnwti - llhogqvysx) View more | ||||||
Phase 4 | 14 | zqexwkvbqu = jnvwsbsrlo jyotscakol (awwcfamsef, lchqepuzee - gxysscmjal) View more | - | 18 Nov 2020 |